Ddavp and Memory loss - a phase IV clinical study of FDA data

Summary:

Memory loss is reported as a side effect among people who take Ddavp (desmopressin acetate), especially for people who are male, 20-29 old, also take Claritin, and have Depression.

The phase IV clinical study analyzes which people have Memory loss when taking Ddavp. It is created by eHealthMe based on reports of 2,531 people who have side effects when taking Ddavp from the FDA, and is updated regularly.

What is Ddavp?

Ddavp has active ingredients of desmopressin acetate. It is often used in diabetes insipidus. eHealthMe is studying from 2,614 Ddavp users. Check the latest studies of Ddavp.

What is Memory loss?

Memory loss is found to be associated with 2,730 drugs and 4,375 conditions by eHealthMe. Check the latest studies of Memory loss.

On Apr, 27, 2026

2,531 people reported to have side effects when taking Ddavp.
Among them, 25 people (0.99%) have Memory loss.

Among these 25 people:

What is the gender of people who have Memory loss when taking Ddavp? *

female: 48 %
male: 52 %

What is the age of people who have Memory loss when taking Ddavp? *

What are other drugs people take besides Ddavp? *

What are other side effects people have besides Memory loss? *

Nausea (feeling of having an urge to vomit): 9 people, 36.00%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 9 people, 36.00%
Tremor (trembling or shaking movements in one or more parts of your body): 8 people, 32.00%
Thirst: 7 people, 28.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 7 people, 28.00%
Loss Of Consciousness: 7 people, 28.00%
Disturbance In Attention: 7 people, 28.00%
Eye Infection: 6 people, 24.00%
Migraine (headache): 6 people, 24.00%
Skin Blushing/flushing (a sudden reddening of the face, neck): 6 people, 24.00%

What are the existing conditions these people have? *

Depression: 3 people, 12.00%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 2 people, 8.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 8.00%
Growth Hormone Deficiency: 2 people, 8.00%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 4.00%
Bipolar Disorder (mood disorder): 1 person, 4.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 4.00%
Diabetes: 1 person, 4.00%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 4.00%
Urinary Tract Disorder: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ddavp and have Memory loss?

- Check whether Memory loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ddavp:

Ddavp (2,614 reports)

Memory loss treatments and more:

Memory loss (244,444 reports)

Browse all side effects of Ddavp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Memory loss:

Memory loss (2,730 drugs)

Browse all the conditions that are associated with Memory loss:

Memory loss (4,375 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on desmopressin acetate (the active ingredients of Ddavp) and Ddavp (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.